CDKN1B and plasma cell myeloma: Expression of CKS1B, which maps to a previously defined amplicon at 1q21 and regulates SCFSkp2-mediated ubiquitination and proteolysis of the CDK inhibitor p27Kip1, was significantly overexpressed in newly diagnosed myeloma patients with a short survival [3, 4].